New chairman for Metalysis


Rotherham, South Yorkshire, UK, 4 June, 2009 – Dr.Pelham Hawker has been appointed chairman of the board of directors of Metalysis Ltd, the technology innovator for the speciality metals industry. Dr. Hawker is also a main board executive director of FTSE 100 speciality chemicals company Johnson Matthey Plc.

Metalysis owns the global Intellectual Property and commercial exploitation rights to the FFC Cambridge Process. When compared to conventional technologies, this process opens up a cheaper, less capital intensive and more environmentally favourable production route to high value metals and alloys.

“Pelham brings a wealth of commercial and operational experience to Metalysis. His expertise, networks and understanding of chemicals engineering and metals technologies, processes and markets will be especially valuable. He will play a crucial role in guiding us through the company’s scale-up and commercialisation phases and on to substantial profitability and market impact”, said Mark Bertolini, chief executive of Metalysis.

Dr. Hawker’s appointment as non-executive chairman follows the successful conclusion of a £5.1million funding round in May 2009, in which all of the company’s venture capital partners have invested further funds. This funding will be used to scale-up manufacturing processes.

Metalysis, based in Rotherham, UK, is focused upon exploiting its disruptive FFC Cambridge Process technology to produce titanium, tantalum, and related high value alloys. These are used increasingly by major worldwide industries such as aerospace, marine, medical, chemical, automotive and electronics industries. The business is already supplying low volumes of metallurgical grade powders. It is projecting modest initial revenues for later this year, with substantially increased sales from 2010 as its semi-continuous pilot plant comes on stream.

Dr. Hawker succeeds industrialist and interim chairman Tony Pedder, also chairman of Sheffield Forgemasters International. Tony Pedder remains on the Metalysis board.

During the last five years Metalysis has raised £19 million in venture capital and a further £4 million in grants. From a workforce of three in 2005, the business now employs 43 people in science and engineering, scale-up and commercial development operations.

Metalysis holds 24 patent families, filed in 88 countries.

 

-ENDS-

 

Issued by The Hannover Consultancy on behalf of Metalysis Ltd. Further enquiries to:

Matthew Pudney/ Rafal Kwiatkowski, The Hannover Consultancy:

 matthew.pudney@hannoverconsultancy.com

 rafal.kwiatkowski@hannoverconsultancy.com

Tel. 00 44 (0)207 602 9222

 

Harry Pepper, Metalysis Ltd

 harry.pepper@metalysis.com

Tel. 00 44 (0) 1709 872111

 

Notes to editor: 

Metalysis

Metalysis Ltd. is the UK’s leading technology business for the global manufacture of special metals and alloys. Using the FFC Cambridge Process, the company has developed an important new technology for producing tantalum, titanium and other metals from the oxide.

The FFC Cambridge Process works for a vast range of metals, alloys and carbides with significant economic and environmental benefits over existing processes. Metalysis owns the worldwide exclusive exploitation rights to the FFC Cambridge Process. 

The Metalysis executive team is led by chief executive, Mark Bertolini and finance director, Harry Pepper.

www.metalysis.com

 

Dr. Pelham Hawker 

Dr Pelham Hawker obtained a degree in Chemistry at the University of Warwick in 1975 and was subsequently awarded a PhD in inorganic chemistry at the University of Bristol. He joined the Agricultural Division of Imperial Chemical Industries in 1978 where he conducted research on heterogeneous catalysts used in the processes for ammonia, methanol and hydrogen manufacture.

After a spell selling catalysts in Eastern Europe and the Arabian Gulf he worked in an ICI new venture business on the development and commercialisation of electrostatic atomisation technology.

He moved to Johnson Matthey Plc in 1985 to become R & D Manager for automotive catalysts. He was appointed Sales and Marketing Director in 1989 and later assumed special responsibilities for the development of diesel emission control. He became Managing Director of Svenska Emissionsteknik, the group’s diesel centre in Sweden in 1995 and in addition President of Johnson Matthey South America in 1997. In May 1999 Dr Hawker became Managing Director of Johnson Matthey's automotive catalyst business in Europe, South America, Africa and India. In 2001 he was appointed Managing Director for the automotive catalyst business worldwide.

He joined the board of Johnson Matthey Plc in 2003 and in 2004 moved to run the company’s Process Catalysts and Technologies Division. In 2006 he gained additional responsibility for the company’s Pharmaceutical Materials Division.

 

Johnson Matthey Plc

Johnson Matthey's principal activities are the manufacture of auto catalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients and the marketing, refining and fabrication of precious metals.